The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

triglycerides     2,3-dimethanoyloxypropyl methanoate

Synonyms: Triformin, Triglycerid, Triglyzerid, AC1NUSQ5, CHEBI:17855, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of triacylglycerol


Psychiatry related information on triacylglycerol


High impact information on triacylglycerol


Chemical compound and disease context of triacylglycerol


Biological context of triacylglycerol


Anatomical context of triacylglycerol


Associations of triacylglycerol with other chemical compounds


Gene context of triacylglycerol

  • Spherical HDL are further remodelled by cholesteryl ester transfer protein (CETP) that transfers cholesteryl esters from HDL to other lipoproteins and by hepatic lipase that hydrolyses HDL triglyceride in processes that reduce HDL size and lead to the dissociation of prebeta-migrating, lipid-poor apolipoprotein (apo)A-I from the particle [34].
  • LPL activity correlated indirectly with lipemia, triglyceride content of HDL2, HL activity, and levels of HDL2 but not of HDL3 [35].
  • Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase [36].
  • LCAT levels correlated significantly with total cholesterol (males, r = 0.384, P < 0.001; females, r = 0.519, P < 0.002); and total triglyceride (only in females, r = 0.512, P < 0.002) [37].
  • Transfection of LDLR(-/-) mice with Ad-RAP strongly increased serum cholesterol and triglyceride levels, but to a lesser extent than those found in LDLR(-/-)/APOC1 mice (39+/-8 and 17+/-8 vs. 52+/-19 and 36+/-19 mmol/liter, respectively) [38].

Analytical, diagnostic and therapeutic context of triacylglycerol


  1. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. Breckenridge, W.C., Little, J.A., Steiner, G., Chow, A., Poapst, M. N. Engl. J. Med. (1978) [Pubmed]
  2. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Smith, S.J., Cases, S., Jensen, D.R., Chen, H.C., Sande, E., Tow, B., Sanan, D.A., Raber, J., Eckel, R.H., Farese, R.V. Nat. Genet. (2000) [Pubmed]
  3. Plasma triglyceride levels and coronary disease. Brunzell, J.D., Austin, M.A. N. Engl. J. Med. (1989) [Pubmed]
  4. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P.A., Bergonzani, M., Gnudi, L., Passeri, M. N. Engl. J. Med. (1989) [Pubmed]
  5. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Broeckel, U., Hengstenberg, C., Mayer, B., Holmer, S., Martin, L.J., Comuzzie, A.G., Blangero, J., Nürnberg, P., Reis, A., Riegger, G.A., Jacob, H.J., Schunkert, H. Nat. Genet. (2002) [Pubmed]
  6. Leptin and the regulation of body weight in mammals. Friedman, J.M., Halaas, J.L. Nature (1998) [Pubmed]
  7. Cross-sectional study of a community with exceptional exposure to DDT. Kreiss, K., Zack, M.M., Kimbrough, R.D., Needham, L.L., Smrek, A.L., Jones, B.T. JAMA (1981) [Pubmed]
  8. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., Pagano, G. Hepatology (2003) [Pubmed]
  9. Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia. Homer, V.M., George, P.M., du Toit, S., Davidson, J.S., Wilson, C.J. Ann. Neurol. (2005) [Pubmed]
  10. Increased triglyceride levels in shift workers. Romon, M., Nuttens, M.C., Fievet, C., Pot, P., Bard, J.M., Furon, D., Fruchart, J.C. Am. J. Med. (1992) [Pubmed]
  11. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Fischer, J., Lef??vre, C., Morava, E., Mussini, J.M., Lafor??t, P., Negre-Salvayre, A., Lathrop, M., Salvayre, R. Nat. Genet. (2007) [Pubmed]
  12. The resequencing imperative. Topol, E.J., Frazer, K.A. Nat. Genet. (2007) [Pubmed]
  13. Positional cloning of the combined hyperlipidemia gene Hyplip1. Bodnar, J.S., Chatterjee, A., Castellani, L.W., Ross, D.A., Ohmen, J., Cavalcoli, J., Wu, C., Dains, K.M., Catanese, J., Chu, M., Sheth, S.S., Charugundla, K., Demant, P., West, D.B., de Jong, P., Lusis, A.J. Nat. Genet. (2002) [Pubmed]
  14. A novel endothelial-derived lipase that modulates HDL metabolism. Jaye, M., Lynch, K.J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., Rader, D.J. Nat. Genet. (1999) [Pubmed]
  15. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. Kraemer, K.H., DiGiovanna, J.J., Moshell, A.N., Tarone, R.E., Peck, G.L. N. Engl. J. Med. (1988) [Pubmed]
  16. Successful hyperlipemic pregnancy. Sanderson, S.L., Iverius, P.H., Wilson, D.E. JAMA (1991) [Pubmed]
  17. Prostaglandins and obesity. Curtis-Prior, P.B. Lancet (1975) [Pubmed]
  18. Effect of sodium oleate on plasma secretin concentration and pancreatic secretion in dog. Faichney, A., Chey, W.Y., Kim, Y.C., Lee, K.Y., Kim, M.S., Chang, T.M. Gastroenterology (1981) [Pubmed]
  19. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Mildvan, D., Machado, S.G., Wilets, I., Grossberg, S.E. Lancet (1992) [Pubmed]
  20. Cyclic AMP-mediated control of lipogenic enzyme synthesis during adipose differentiation of 3T3 cells. Spiegelman, B.M., Green, H. Cell (1981) [Pubmed]
  21. Effect of severe burn injury on substrate cycling by glucose and fatty acids. Wolfe, R.R., Herndon, D.N., Jahoor, F., Miyoshi, H., Wolfe, M. N. Engl. J. Med. (1987) [Pubmed]
  22. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. Cox, D.W., Breckenridge, W.C., Little, J.A. N. Engl. J. Med. (1978) [Pubmed]
  23. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland, I.F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., Wynn, V. N. Engl. J. Med. (1990) [Pubmed]
  24. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Green, H., Kehinde, O. Cell (1975) [Pubmed]
  25. The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. Kern, P.A., Ong, J.M., Saffari, B., Carty, J. N. Engl. J. Med. (1990) [Pubmed]
  26. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. An, J., Muoio, D.M., Shiota, M., Fujimoto, Y., Cline, G.W., Shulman, G.I., Koves, T.R., Stevens, R., Millington, D., Newgard, C.B. Nat. Med. (2004) [Pubmed]
  27. Complete protein sequence and identification of structural domains of human apolipoprotein B. Knott, T.J., Pease, R.J., Powell, L.M., Wallis, S.C., Rall, S.C., Innerarity, T.L., Blackhart, B., Taylor, W.H., Marcel, Y., Milne, R. Nature (1986) [Pubmed]
  28. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. Grundy, S.M. N. Engl. J. Med. (1986) [Pubmed]
  29. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. Haller, R.G., Lewis, S.F. N. Engl. J. Med. (1991) [Pubmed]
  30. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Guan, H.P., Li, Y., Jensen, M.V., Newgard, C.B., Steppan, C.M., Lazar, M.A. Nat. Med. (2002) [Pubmed]
  31. Oral contraceptives and physiological variables. Ostrander, L.D., Lamphiear, D.E., Block, W.D., Williams, G.W., Carmen, W.J. JAMA (1980) [Pubmed]
  32. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. Graudal, N.A., Galløe, A.M., Garred, P. JAMA (1998) [Pubmed]
  33. Conversion of low density lipoprotein-associated phosphatidylcholine to triacylglycerol by primary hepatocytes. Minahk, C., Kim, K.W., Nelson, R., Trigatti, B., Lehner, R., Vance, D.E. J. Biol. Chem. (2008) [Pubmed]
  34. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Barter, P.J. Atherosclerosis. Supplements. (2002) [Pubmed]
  35. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. Patsch, J.R., Prasad, S., Gotto, A.M., Patsch, W. J. Clin. Invest. (1987) [Pubmed]
  36. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. Rubinstein, A., Gibson, J.C., Paterniti, J.R., Kakis, G., Little, A., Ginsberg, H.N., Brown, W.V. J. Clin. Invest. (1985) [Pubmed]
  37. Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. Albers, J.J., Adolphson, J.L., Chen, C.H. J. Clin. Invest. (1981) [Pubmed]
  38. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. Jong, M.C., Dahlmans, V.E., van Gorp, P.J., van Dijk, K.W., Breuer, M.L., Hofker, M.H., Havekes, L.M. J. Clin. Invest. (1996) [Pubmed]
  39. Selective deficiency of hepatic triglyceride lipase in uremic patients. Mordasini, R., Frey, F., Flury, W., Klose, G., Greten, H. N. Engl. J. Med. (1977) [Pubmed]
  40. Increased lipoprotein-remnant formation in chronic renal failure. Nestel, P.J., Fidge, N.H., Tan, M.H. N. Engl. J. Med. (1982) [Pubmed]
  41. Role of LXRs in control of lipogenesis. Schultz, J.R., Tu, H., Luk, A., Repa, J.J., Medina, J.C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D.J., Lustig, K.D., Shan, B. Genes Dev. (2000) [Pubmed]
  42. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Gardner, C.D., Fortmann, S.P., Krauss, R.M. JAMA (1996) [Pubmed]
WikiGenes - Universities